Therapeutic Drug Monitoring: Last Dose, Sample Time and Interpretation
Document actual dosing and collection times, formulation and test purpose; distinguish a twelve-hour lithium sample from other medicine-specific monitoring plans.
Hormone tests should be booked around the clinical question and laboratory method, not one universal 'morning fasting' rule. Cortisol, testosterone, prolactin and thyroid investigations have different timing and interpretation issues. Record the actual collection time, relevant medicines and supplements, sleep or shift-work context and any preparation deviation. Do not move, withhold or restart treatment solely to fit a generic booking template.
Indian general, endocrine and reproductive-health clinics coordinating hormone investigations with outside laboratories.
A hormone panel can combine investigations ordered for different reasons: suspected deficiency, a treatment review, a pituitary question or a dynamic test. The same analyte name does not guarantee that every request uses the same preparation or interpretation. Identify the purpose and the responsible clinician before giving timing advice.
Separate basal sampling from a stimulated or suppressed test and from a measurement linked to a medicine dose. These are different procedures. A reception shortcut labelled 'all hormones at 8 am' cannot safely describe all of them.
Confirm the receiving laboratory and current instruction. If several tests are requested together, identify whether their conditions can genuinely be met in one visit. A convenient combined booking should not override a test-specific clinical plan.
NICE NG243 recommends an 8–9 am serum cortisol measurement for people aged one year and over when adrenal insufficiency is suspected. Its guidance also discusses medicine effects and assay-dependent interpretation. This is a defined clinical situation, not a statement that every cortisol investigation has the same timing.
Record relevant glucocorticoid exposure, including products used by different routes, and obtain the clinician's specific preparation instructions. Staff should not extrapolate a medicine-withholding rule from one guideline section to every person booked for a cortisol measurement.
A patient who has worked overnight needs the sleep/work history communicated to the clinician or laboratory. Do not simply rename a later clock time 'their morning' and apply the usual interpretation. If acute illness requires assessment, care should not wait for a routine laboratory appointment.
The Endocrine Society's 2018 guideline recommends confirming suspected male hypogonadism with repeat morning fasting total-testosterone measurements in the relevant clinical setting. It also requires compatible symptoms and signs rather than a diagnosis from one isolated number. That scope matters when a clinic receives a low result from an unrelated panel.
Treatment monitoring may involve a different relationship to the administered product. Record the formulation and actual use, and obtain the responsible clinician's instruction rather than reusing the diagnostic-testing leaflet.
A laboratory or assay change can also affect comparability. Preserve the original report and its units, reference information and collection conditions. A graph that joins values without this context can make a preparation difference look like a treatment response.
Source: Endocrine Society: Testosterone Therapy in Men With Hypogonadism, 2018
The Endocrine Society's 2011 hyperprolactinaemia guideline describes avoiding excessive venepuncture stress and allows initial prolactin sampling at different times of day. It is an older, indication-specific reference; current local laboratory or specialist instructions may add conditions. Its value here is to show why an all-hormones timing slogan is inadequate.
Record relevant circumstances rather than rewriting them into an idealised account. If the patient rushed from work, had a difficult collection or did not follow the issued preparation, the clinician needs the actual facts. Staff should not infer that every unexpected result is caused by stress.
For thyroid investigations, NICE NG145 specifically asks about biotin intake because high supplement consumption can interfere with results. Ask about hair, skin and nail supplements as well as prescribed medicines. A yes/no 'regular medication' field can miss products the patient does not consider medicines.
The appropriate response to reported biotin use depends on the assay and clinical plan. Do not publish one universal interruption duration or tell every patient to stop thyroid treatment. Preserve the product and reported use, then obtain laboratory or clinician advice.
Source: Endocrine Society: Diagnosis and Treatment of Hyperprolactinemia, 2011
This original map identifies questions to resolve. It is not a hormone-testing protocol, diagnostic threshold table or instruction to delay urgent care.
On a narrow screen, scroll the table horizontally to read all columns.
| Request | Information to clarify | Mistake to avoid |
|---|---|---|
| Cortisol for a specified clinical question | Indication, sampling plan, glucocorticoid exposure and assay context | Applying one clock rule to every cortisol procedure |
| Diagnostic testosterone measurement | Clinical purpose, agreed conditions and repeat-plan ownership | Diagnosing from an isolated low panel result |
| Testosterone treatment review | Product, actual administration and prescribed sampling relationship | Copying the untreated diagnostic leaflet |
| Prolactin investigation | Local preparation, medicines and actual collection circumstances | Treating a stress explanation as a confirmed diagnosis |
| Thyroid tests | Clinical question, treatment and relevant supplement use | Ignoring biotin because it was bought without a prescription |
| Shift-work or combined panel | Sleep/work account and compatibility of test conditions | Inventing a common time that no responsible service approved |
Consider a fictional patient with one hormone result collected after a night shift at 16:40 and another obtained under an agreed morning plan at 08:20. The second result is not automatically a biological improvement or deterioration. The clinician first needs to know that collection context changed.
Do not erase the first value or relabel its time to make the graph consistent. Retain both reports and annotate the differences. If one result requires repeat testing under specified conditions, link that decision to the original question rather than generating an unexplained duplicate order.
A useful result view separates the numeric trend from comparability information. It should show actual specimen time and relevant context without implying that software has clinically adjusted the value for sleep, food or medicine effects.
Give the patient one current, approved preparation plan and a contact route for uncertainty. A person travelling from a distant town needs to know the practical appointment arrangements before changing their day or missing work. If a combined visit is not possible, explain which requirement creates the extra visit.
At collection, record the actual circumstances and any changed medicine or supplement use. At review, keep that information available with the result. Information gathered only in a booking note may be missed if the doctor sees an imported number without the note.
The following outline supports that handover. For a software demonstration, use a fictional night-shift worker and a newly reported supplement to test whether the preparation plan can be revised without overwriting the earlier account.
A patient booked for thyroid testing mentions a hair supplement only when the collection team asks about non-prescription products. Staff record the product and reported use and obtain the laboratory's advice, rather than assuming the original preparation checklist is complete. The clinician sees that context with the result. No one invents a universal supplement washout or changes the patient's prescribed thyroid medicine through the booking system.
Use these prompts in your clinic’s own notes. Record the result, responsible person and next action for each item.
No. Requirements depend on the analyte, clinical purpose, treatment and laboratory method. Confirm the specific plan instead of using one panel-wide rule.
Do not invent an equivalent time. Communicate the sleep/work pattern and obtain the appropriate clinician or laboratory plan for the question being investigated.
The cited Endocrine Society diagnostic guidance requires the relevant clinical picture and confirmatory testing under appropriate conditions. An isolated panel value should be reviewed in that context.
Some contain biotin, which can interfere with certain thyroid-test results. Record the product and actual use and seek assay-specific advice rather than applying a universal interruption period.
No. Laboratory acceptance and clinical interpretation are different questions. Keep the actual collection circumstances available to the reviewing clinician.
Updated on . This article combines the cited references with Bractis’s original workflow analysis and illustrative examples. Product capabilities depend on the configured scope. No independent clinical or legal review is claimed.
UK indication-specific cortisol timing and interpretation context. No treatment threshold or glucocorticoid-withholding regimen is reproduced.
Primary guideline for a defined diagnostic population; not a universal instruction for all testosterone tests.
Older primary guideline illustrating the importance of stress and test context. Current laboratory/specialist instructions remain necessary.
The biotin recommendation was added in 2023. Indexed official text was reviewed after a direct retrieval returned 403; no universal washout is inferred.
Document actual dosing and collection times, formulation and test purpose; distinguish a twelve-hour lithium sample from other medicine-specific monitoring plans.
Identify the ordered glucose-test protocol before scheduling, anchor timers to the actual protocol-defined event and record collection deviations honestly.
Reconcile kidney reports, check indexed eGFR conversions and prevent double BSA adjustment with worked examples for Indian clinic prescribing reviews.
Review fictional serial hormone results with changed collection times and supplement history; verify that the graph, source report and preparation context stay connected.
Request a clinic demo